A detailed history of Pax Financial Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Pax Financial Group, LLC holds 1,888 shares of ABBV stock, worth $339,840. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,888
Previous 1,599 18.07%
Holding current value
$339,840
Previous $274,000 35.77%
% of portfolio
0.07%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $47,349 - $57,606
289 Added 18.07%
1,888 $372,000
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $63,309 - $73,930
409 Added 34.37%
1,599 $274,000
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $190,185 - $216,699
1,190 New
1,190 $216,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pax Financial Group, LLC Portfolio

Follow Pax Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pax Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pax Financial Group, LLC with notifications on news.